Upexi (UPXI) risk factors, FY2024 10-K

Upexi's FY2024 10-K, filed Dec 16, 2024, lists 31 risk factors in 3 groups. There is no earlier 10-K to compare against, so the most company-specific risks are listed below.

Risk factors listed
313 groups
Section length
7k wordsItem 1A

Upexi's biggest risks in the FY2024 10-K

  • Upexi faces intense competition in the hemp-based and CBD product market against better-resourced rivals.
  • Evolving federal and state regulations under the Farm Bill heavily impact CBD processing and product compliance.
  • The company relies on short-term supplier contracts for industrial hemp and independent distributors for direct sales.

The risks most specific to Upexi

  • Risks Relating to Our Business and Industry

    We operate in a highly competitive environment, and if we are unable to compete with our competitors, our business, financial condition, results of operations, cash flows and prospects could be materially adversely affected

    We compete in the hemp-based product industry against well-resourced competitors with greater resources.

  • Risks Relating to Our Business and Industry

    Loss of key contracts with our suppliers, renegotiation of such agreements on less favorable terms or other actions these third parties may take could harm our business

    Our industrial hemp agreements with suppliers are mostly short-term contracts whose loss would harm our raw material procurement.

  • Risks Relating to Our Business and Industry

    We may be unable to attract and retain independent distributors for our products

    As a direct selling company, our revenue depends on independent distributors who experience high turnover rates.

  • Risks Related to the CBD Industry

    Laws and regulations affecting the CBD industry are evolving under the Farm Bill, and changes to applicable regulations may materially affect our future operations in the CBD market

    The CBD we use is derived from hemp under the Farm Bill, and regulatory changes could materially affect our operations.

  • Risks Related to the CBD Industry

    Unfavorable interpretations of laws governing hemp processing activities could subject us to enforcement or other legal proceedings and limit our business and prospects

    Federal and state law lack explicit protections for temporarily exceeding 0.3% THC during interim hemp processing stages.

  • Risks Related to the CBD Industry

    Costs associated with compliance with various laws and regulations could negatively impact our financial results

    The FDA regulates our CBD products to ensure they are not adulterated or misbranded.

  • Risks Related to the CBD Industry

    Uncertainty caused by potential changes to legal regulations could impact the use and acceptance of CBD products

    Uncertainty exists among regulatory agencies regarding Farm_Bill-compliant hemp programs relative to the Controlled Substances Act.

All 31 risk factors

Headings as the filing states them, in filing order.

Risks Relating to Our Company

  1. 01Our limited operating history makes it difficult for potential investors to evaluate our business prospects and management
  2. 02If we are unable to protect our intellectual property rights, our competitive position could be harmed
  3. 03We may not be able to effectively manage growth
  4. 04Our management may not be able to control costs in an effective or timely manner
  5. 05We expect our quarterly financial results to fluctuate
  6. 06We are subject to the reporting requirements of U.S. federal securities laws, which can be expensive
  7. 07We may incur significant costs and require significant management resources to evaluate our internal control over financial reporting as required under Section 404 of the Sarbanes-Oxley Act, and any failure to comply or any adverse result from such evaluation may have an adverse effect on our stock price
  8. 08Increases in costs, disruption of supply or shortage of raw materials could harm our business
  9. 09Our failure to meet the continuing listing requirements of the NASDAQ Capital Market could result in a de-listing of our securities
  10. 10We will incur increased costs and demands upon management as a result of complying with the laws and regulations affecting public companies, which could adversely affect our operating results

Risks Relating to Our Business and Industry

  1. 11We operate in a highly competitive environment, and if we are unable to compete with our competitors, our business, financial condition, results of operations, cash flows and prospects could be materially adversely affected
  2. 12Unfavorable publicity or consumer perception of our products or similar products developed and distributed by other companies could have a material adverse effect on our reputation, which could result in decreased sales and fluctuations in our business, financial condition and results of operations
  3. 13Our failure to appropriately and timely respond to changing consumer preferences and demand for new products could significantly harm our customer relationships and have a material adverse effect on our business, financial condition and results of operations
  4. 14Future acquisitions or strategic investments and partnerships could be difficult to identify and integrate with our business, disrupt our business, and adversely affect our financial condition and results of operations
  5. 15Failure to successfully integrate acquired businesses and their products and other assets into our Company, or if integrated, failure to further our business strategy, may result in our inability to realize any benefit from such acquisition
  6. 16The failure to attract and retain key employees could hurt our business
  7. 17We have limited supply sources, and price increases or supply shortages of key raw materials could materially and adversely affect our business, financial condition and results of operations
  8. 18Loss of key contracts with our suppliers, renegotiation of such agreements on less favorable terms or other actions these third parties may take could harm our business
  9. 19There is limited availability of clinical studies
  10. 20We face substantial risk of product liability claims and potential adverse product publicity
  11. 21We may be unable to attract and retain independent distributors for our products
  12. 22competition in the market
  13. 23We could incur obligations resulting from the activities of our independent distributors
  14. 24If our independent distributors’ failure to comply with applicable advertising laws and regulations could adversely affect our financial conditions and results of operations

Risks Related to the CBD Industry

  1. 25Laws and regulations affecting the CBD industry are evolving under the Farm Bill, and changes to applicable regulations may materially affect our future operations in the CBD market
  2. 26Unfavorable interpretations of laws governing hemp processing activities could subject us to enforcement or other legal proceedings and limit our business and prospects
  3. 27Costs associated with compliance with various laws and regulations could negatively impact our financial results
  4. 28Uncertainty caused by potential changes to legal regulations could impact the use and acceptance of CBD products
  5. 29If we fail to obtain necessary permits, licenses and approvals under applicable laws and regulations, our business and plan of operations may be adversely impacted
  6. 30Potential future international expansion of our business could expose us to additional regulatory risks and compliance costs
  7. 31The market for health and wellness products is highly competitive. If we are unable to compete effectively in the market, our business and operating results could be materially and adversely affected

Other Upexi 10-Ks

  • FY2026 10-K risk factors
    46 risks8 new14 dropped4 reworded

    The company added significant risks regarding its new Solana treasury strategy, governance, and validator operations, while dropping industrial hemp and CBD regulatory risks.

    Filed Sep 17, 2026
  • FY2025 10-K risk factors
    52 risks21 new

    Upexi faces significant new strategic risks centering on cryptocurrency investments, specifically holding Solana as a treasury asset. Regulatory uncertainty regarding whether Solana constitutes a security under federal law could severely impact the business. Potential classification under the Investment Company Act of 1940 could make operations impractical.

    Filed Sep 24, 2025

About this page

The headings are the filing's own. The one-line readings and the overview are automated and can be wrong: read Item 1A of the 10-K for the exact wording.